Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dalton Pharma Services, a contract pharmaceutical manufacturing company, has renewed its chemistry services agreement with Boehringer Ingelheim Canada.
Subscribe to our email newsletter
Under the agreement Dalton will continue to provide chemistry services in support of Boehringer’s pharmaceutical development programs.
Peter Pekos, president of Dalton Pharma Services, said: “We are extremely pleased to continue our relationship with Boehringer Ingelheim Canada. The renewal of our chemistry services agreement demonstrates Boehringer Ingelheim’s deep commitment to research in Canada. We look forward to another successful collaboration with this world-class organization.”